In the June 14, 2010 issue of Chemical and Engineering News, bioVidria’s nanoparticle technology will be highlighted in the publication’s coverage of the most recent advances in chromatography. In addition, Dr. Mary Wirth, Chairman of bioVidria’s Board of Directors and professor at Purdue University, will be presenting this same technology and its application to in [...]
Continue Reading .:Corey Smith, bioVidria’s CEO and President, spoke on a panel at the Southwest Bioscience Expo in Tucson, Arizona at the Marriott Starr Pass Resort on May 21. He participated in a panel titled “An Entrepreneur’s Guide: Start-Up to Success” alongside other biotechnology startup companies. He also presented bioVidria’s technology during the Expo’s Company Showcase that [...]
Continue Reading .:Dr. Mary Wirth, Chairman of the Board of Directors, recently has been named a Fellow by the American Association for the Advancement of Science. This distinction was given based on Dr. Wirth’s innovations in bioanalytical chemistry, with unique expertise in creating new materials for fast and sensitive protein characterization and for leadership through organizing symposium [...]
Continue Reading .:By La Monica Everett-Haynes, University of Arizona Communications
June 26, 2009
Part of the difficulty in detecting diseases like cancer early on is that the instruments available to hunt for the minute proteins indicative of a disease are not advanced enough.
The evidence is often right in the bloodstream but “blood tests are not always sensitive enough,” said [...]
(BIO5 Institute – The University of Arizona) A company based on a University of Arizona chemist’s research may one day speed drug discovery and disease detection.
The new company, bioVidria, was started by Mary Wirth, UA Professor of Chemistry and a BIO5 member. BioVidria takes microarrays―slides containing collections of molecules that are used to detect other [...]